Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Reexamination Certificate
2011-05-17
2011-05-17
Henley, III, Raymond (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
C514S509000, C424S718000
Reexamination Certificate
active
07943667
ABSTRACT:
Treatment of or prophylaxis against the occurrence of pulmonary disorders associated with hypoxemia and/or smooth muscle constriction or infection in the lungs comprises administration into the lung(s) as a gas composition comprising nitric oxide, e.g. ethyl nitrite or nitric oxide, and also administering into the lungs L-cysteine. The pulmonary disorder can be persistent pulmonary hypertension of the newborn to increase SpO2 and decrease systolic blood pressure. In another case administration is to a premature newborn to prophylax against the development of bronchopulmonary dysplasia.
REFERENCES:
patent: 5485827 (1996-01-01), Zapol et al.
patent: 2004/0224899 (2004-11-01), Gaston et al.
S. Singh et al., Nitric oxide, the biological mediator of the decade: fact or fiction?, European Respiratory Journal, 1997, pp. 699-707.
Auten Richard L.
Whorton Richard
Bacon & Thomas PLLC
Duke University
Henley III Raymond
LandOfFree
Potentiating the effect of compound comprising nitric oxide does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Potentiating the effect of compound comprising nitric oxide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Potentiating the effect of compound comprising nitric oxide will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2630609